车载自动化是否可以帮助患有帕金森病的人? 一个初步分析
Wayne C W Giang1, Haolan Zheng1, Beth Gibson2
1Department of Industrial and Systems Engineering, Herbert Wertheim College of Engineering, University of Florida, Gainesville, FL, United States.
Frontiers in neurology
|October 30, 2023
概括
先进的驾驶辅助系统 (ADAS) 和车载信息系统 (IVIS) 减少了帕金森病 (PD) 患者的驾驶错误. 自动化通过减少对驾驶安全的认知影响,为驾驶者带来好处.
科学领域:
- 神经科学是一个神经科学.
- 康复医学 康复医学 康复医学
- 人类因素工程 人类因素工程
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病,影响认知,视觉和运动功能.
- 这些障碍显著影响驾驶表现,这是影响独立性的关键日常活动.
- 虽然PD的驾驶障碍已被记录在案,但车载自动化技术在现实世界中所带来的好处仍未得到充分探索.
研究的目的:
- 调查车载信息系统 (IVIS) 和先进驾驶辅助系统 (ADAS) 对PD患者驾驶安全的影响.
- 确定自动化技术是否可以减轻驾驶错误,并减少认知缺陷对驾驶性能的影响.
主要方法:
- 45名被诊断患有PD的成年人参加了一项道路驾驶研究.
- 参与者驾驶了一辆配备IVIS和ADAS (丰田安全感2.0) 的车辆,在各种道路类型上行驶.
- 驾驶性能通过比较系统激活与关闭时犯下的错误数量来评估.
主要成果:
- 假设驾驶控制的自动化系统,如自适应巡航控制,最有效地减少了驾驶错误.
- 当系统关闭时,认知能力,特别是记忆,与驾驶错误相关,但当系统打开时,这种相关性消失了.
- 身体PD症状 (刚性,勃拉迪基尼西亚) 与驾驶错误没有显著的相关性.
结论:
- 车载驾驶员自动化系统为患有PD的驾驶员带来了显著的好处.
- 这些技术可以有效地减少个体认知差异对驾驶安全的影响.
- 自动化有望提高PD患者的流动性和独立性.
更多相关视频
06:32Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
1.3K
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
3.8K
相关概念视频
Parkinson's Disease: Treatment
281
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
281
Parkinson's Disease: Overview
567
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
567
